Mark M. Jones
- Genetics top 0.5%
- Molecular Biology top 10%
- Oncology top 5%
- Hematology top 1%
- Health, Toxicology and Mutagenesis top 1%
- Co-authors
- James BlairAlessandro M. VannucchiJean‐Jacques KiladjianKarina S. BlairClaire HarrisonMark A. BasingerAlayne B. SmithShirley G. Jones
- Topics
- Heavy Metal Exposure and Toxicity (53 papers)Trace Elements in Health (39 papers)Acute Myeloid Leukemia Research (16 papers)
- Journals
- New England Journal of MedicineJournal of the American Chemical SocietyJournal of Clinical Oncology
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Mark M. Jones
185 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Genetics 1.0k
- Molecular Biology 917
- Oncology 910
- Hematology 769
- Health, Toxicology and Mutagenesis 756
Countries citing papers authored by Mark M. Jones
This map shows the geographic impact of Mark M. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Jones more than expected).
Fields of papers citing papers by Mark M. Jones
This network shows the impact of papers produced by Mark M. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Jones. The network helps show where Mark M. Jones may publish in the future.
Co-authorship network of co-authors of Mark M. Jones
This figure shows the co-authorship network connecting the top 25 collaborators of Mark M. Jones. A scholar is included among the top collaborators of Mark M. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark M. Jones. Mark M. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind studybreakdown → | 703 |
| 7 | Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosisbreakdown → | 350 |
| 8 | 17 | |
| 9 | 215 | |
| 10 | 132 | |
| 11 | 1 | |
| 12 | 29 | |
| 13 | 10 | |
| 14 | 33 | |
| 15 | 6 | |
| 16 | 8 | |
| 17 | 2 | |
| 18 | 5 | |
| 19 | Chemistry, man, and society | 0 |
| 20 | Ligand reactivity and catalysis | 42 |
About Mark M. Jones
Mark M. Jones is a scholar working on Health, Toxicology and Mutagenesis, Nutrition and Dietetics and Filtration and Separation, having authored 193 papers that have together received 4.9k indexed citations. Recurring topics across this work include Heavy Metal Exposure and Toxicity (53 papers), Trace Elements in Health (39 papers) and Acute Myeloid Leukemia Research (16 papers). The work is most often cited by research in Biological Psychiatry (263 citations), Genetics (1.0k citations) and Hematology (769 citations). Mark M. Jones has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include James Blair, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Karina S. Blair, Claire Harrison, Mark A. Basinger, Alayne B. Smith, Shirley G. Jones, Glen R. Gale and Pramod K. Singh. Their work appears in journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.